World Health Organization Rules CBD should Not be Schedule I
For years, activists have been fighting in many countries to get cannabis rescheduled or de-scheduled, so that it is no longer considered a dangerous substance. While many are still reluctant to do this, there has been some progress made on rescheduling CBD, the non-psychoactive component in cannabis. Recently, the World Health Organization ruled that CBD should no longer be considered a Schedule I drug.
According to High Times, the WHO has officially ruled that CBD is not schedule I. Their review of the substance revealed that CBD has medical value because it treats epilepsy, and that there is little potential for addiction or abuse, since it is not a psychoactive substance. As of now, they have decided that it is not worthy of scheduling at all. Another review in May 2018 will re-evaluate if it should be listed as another Schedule.
According to Network Newswire,, the offical report read, “In humans, CBD exhibits no effects indicative of any abuse or dependence potential.” The report further indicates that, “CBD is generally well tolerated and with a good safety profile. Reported adverse effects may be as a result of drug-drug interactions between CBD and patients’ existing medications.”
This is a major step towards acceptance of cannabis worldwide, and should provide a beacon to less-accepting countries that CBD has the potential to heal, not to hurt.